Table 2.

Characteristics of HCC cases by HBV and HCV liver tissue status (n = 61)

HBV+ (n = 20)HBV− (n = 41)HCV+ (n = 7)HCV− (n = 54)
Characteristicsn (%)n (%)Pn (%)n (%)P
Sex
 Male15 (75)28 (68)0.595 (71)38 (70)0.95
 Female5 (25)13 (32)2 (29)16 (30)
Age, y
 <6013 (65)23 (56)0.513 (43)33 (61)0.36
 ≥607 (35)18 (44)4 (57)21 (39)
Racea
 White0 —10 (24)0.041 (14)9 (17)0.16
 Asian/Pacific Islander20 (100)31 (76)6 (86)45 (83)
Birthplaceb
 United States15 (79)11 (33)0.0023 (50)23 (50)1.00
 Asia and Pacific Island4 (21)22 (67)3 (50)23 (50)
Diagnosis year
 1990–19997 (35)15 (37)0.900 –22 (41)0.03
 2000–201013 (65)26 (63)7 (100)32 (59)
Stage
 Localized14 (70)29 (71)0.874 (57)39 (72)0.21
 Regional/Distant5 (25)11 (27)2 (29)14 (26)
 Unstaged/Unknown1 (5)1 (2)1 (14)1 (2)
Cirrhosisc
 No6 (35)16 (43)0.582 (29)20 (43)0.48
 Yes11 (65)21 (57)5 (71)27 (57)
First course of treatment
 Surgeryd17 (85)31 (76)0.406 (86)42 (78)0.63
 Other/None3 (15)10 (24)1 (14)12 (22)

NOTE: Based on the detection of HBV (HBV DNA, HBsAg, and/or HBcAg) in tumor and/or non-tumor liver tissue and on the detection of HCV RNA in tumor and/or non-tumor liver tissue.

  • aExcludes race other than white, Asian, and Pacific Islander.

  • bExcludes birthplace other than United States, Asia, and Pacific Islands; United States includes U.S. mainland and Hawaii only.

  • cExcludes 7 cases with no information on cirrhosis status.

  • dSurgical resection or transplantation.